FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309658575> ?p ?o ?g. }

• W4309658575 endingPage "153473542211372" @default.
• W4309658575 startingPage "153473542211372" @default.
• W4309658575 abstract "Chemotherapy is associated with decreased quality of life (QOL), fatigue, depression, and weight gain in patients with breast cancer. Weight gain is associated with poorer prognosis. Yoga improves QOL, fatigue, and mood in women with breast cancer but its effect on treatment-related weight gain has not been studied. The aim of this trial was to determine the feasibility of personalized yoga therapy in women receiving treatment for early-stage or locally advanced breast cancer and assess its impact on weight gain.Thirty women were randomized 1:1 to receive yoga therapy by a certified yoga therapist during treatment or a control group. Participants in the yoga arm were asked to complete three 30 minute yoga sessions weekly (which included movement, breath work, mindfulness, and relaxation) throughout adjuvant or neoadjuvant chemotherapy (N = 29) or endocrine (N = 1); the control arm received breast cancer treatment without yoga. For comparability between participants randomized to yoga therapy, the single patient treated with endocrine therapy was excluded from the analysis. Primary outcomes were feasibility and weight change. Additional outcomes were mood, fatigue, QOL, serum tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP) as immune mediator biomarkers.Mean age was 51.6 years, 75.9% were white and 24.1% were people of color, reflecting the cancer center population. 80% had stage II-III disease. Enrollment was completed in 9 months. Compliance was lower than predicted; however, participants participated in on average 1.7 yoga sessions/week for a mean 15.6 weeks duration. There were no adverse events. Control arm participants gained on average 2.63% body weight during treatment while yoga participants lost 0.14% body weight (weight change = -0.36 in yoga arm vs. 2.89 in standard of care arm, Wilcoxon rank sum test P = .024). Control participants reported increased fatigue and decreased QOL, while yoga participants reported no change in QOL. No significant change in TNF-alpha or CRP was noted in either arm.This feasibility study suggests that personalized yoga therapy is beneficial for QOL and weight maintenance among women undergoing chemotherapy for early-stage or locally advanced breast cancer. Weight maintenance associated with yoga therapy may be of clinical significance in this population given the poorer prognosis associated with weight gain in breast cancer survivors.NIH Clinicaltrials.gov #NCT03262831; August 25, 2017. https://clinicaltrials.gov/ct2/show/NCT03262831." @default.
• W4309658575 created "2022-11-29" @default.
• W4309658575 creator A5017683376 @default.
• W4309658575 creator A5036526586 @default.
• W4309658575 creator A5037696116 @default.
• W4309658575 creator A5037815706 @default.
• W4309658575 creator A5039998213 @default.
• W4309658575 creator A5043433751 @default.
• W4309658575 creator A5046828727 @default.
• W4309658575 creator A5049583085 @default.
• W4309658575 creator A5059061728 @default.
• W4309658575 creator A5063285199 @default.
• W4309658575 creator A5063672208 @default.
• W4309658575 creator A5082172901 @default.
• W4309658575 date "2022-01-01" @default.
• W4309658575 modified "2023-10-14" @default.
• W4309658575 title "Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer" @default.
• W4309658575 cites W1485309286 @default.
• W4309658575 cites W1833172369 @default.
• W4309658575 cites W1917834448 @default.
• W4309658575 cites W1990613023 @default.
• W4309658575 cites W2000525505 @default.
• W4309658575 cites W2008566565 @default.
• W4309658575 cites W2018315438 @default.
• W4309658575 cites W2019466900 @default.
• W4309658575 cites W2031680872 @default.
• W4309658575 cites W2051918740 @default.
• W4309658575 cites W2052254431 @default.
• W4309658575 cites W2060507602 @default.
• W4309658575 cites W2061672059 @default.
• W4309658575 cites W2070241894 @default.
• W4309658575 cites W2074290559 @default.
• W4309658575 cites W2082707094 @default.
• W4309658575 cites W2101868160 @default.
• W4309658575 cites W2108696783 @default.
• W4309658575 cites W2109659496 @default.
• W4309658575 cites W2111975921 @default.
• W4309658575 cites W2114772689 @default.
• W4309658575 cites W2115395024 @default.
• W4309658575 cites W2119968490 @default.
• W4309658575 cites W2120051206 @default.
• W4309658575 cites W2125508082 @default.
• W4309658575 cites W2126460406 @default.
• W4309658575 cites W2131208412 @default.
• W4309658575 cites W2133441071 @default.
• W4309658575 cites W2145309702 @default.
• W4309658575 cites W2148560487 @default.
• W4309658575 cites W2148886798 @default.
• W4309658575 cites W2162897974 @default.
• W4309658575 cites W2167304097 @default.
• W4309658575 cites W2167409896 @default.
• W4309658575 cites W2171467964 @default.
• W4309658575 cites W2278760204 @default.
• W4309658575 cites W2557299371 @default.
• W4309658575 cites W2566963236 @default.
• W4309658575 cites W2593401032 @default.
• W4309658575 cites W2753529942 @default.
• W4309658575 cites W2754611997 @default.
• W4309658575 cites W2894213826 @default.
• W4309658575 cites W2917562616 @default.
• W4309658575 cites W3011456563 @default.
• W4309658575 cites W3033718997 @default.
• W4309658575 cites W3194835444 @default.
• W4309658575 cites W4236805817 @default.
• W4309658575 cites W4282933575 @default.
• W4309658575 doi "https://doi.org/10.1177/15347354221137285" @default.
• W4309658575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36412916" @default.
• W4309658575 hasPublicationYear "2022" @default.
• W4309658575 type Work @default.
• W4309658575 citedByCount "0" @default.
• W4309658575 crossrefType "journal-article" @default.
• W4309658575 hasAuthorship W4309658575A5017683376 @default.
• W4309658575 hasAuthorship W4309658575A5036526586 @default.
• W4309658575 hasAuthorship W4309658575A5037696116 @default.
• W4309658575 hasAuthorship W4309658575A5037815706 @default.
• W4309658575 hasAuthorship W4309658575A5039998213 @default.
• W4309658575 hasAuthorship W4309658575A5043433751 @default.
• W4309658575 hasAuthorship W4309658575A5046828727 @default.
• W4309658575 hasAuthorship W4309658575A5049583085 @default.
• W4309658575 hasAuthorship W4309658575A5059061728 @default.
• W4309658575 hasAuthorship W4309658575A5063285199 @default.
• W4309658575 hasAuthorship W4309658575A5063672208 @default.
• W4309658575 hasAuthorship W4309658575A5082172901 @default.
• W4309658575 hasBestOaLocation W43096585753 @default.
• W4309658575 hasConcept C118552586 @default.
• W4309658575 hasConcept C121608353 @default.
• W4309658575 hasConcept C126322002 @default.
• W4309658575 hasConcept C159110408 @default.
• W4309658575 hasConcept C168563851 @default.
• W4309658575 hasConcept C1862650 @default.
• W4309658575 hasConcept C2779951463 @default.
• W4309658575 hasConcept C2780733359 @default.
• W4309658575 hasConcept C2908647359 @default.
• W4309658575 hasConcept C530470458 @default.
• W4309658575 hasConcept C71924100 @default.
• W4309658575 hasConcept C99454951 @default.
• W4309658575 hasConceptScore W4309658575C118552586 @default.
• W4309658575 hasConceptScore W4309658575C121608353 @default.

• next